ArticleVirus research2026
Impacts of delayed influenza vaccination on clinical outcomes in ICU-admitted patients with influenza: A retrospective cohort study.
Article in Virus research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfluenza vaccination is an effective measure for reducing the risk of severe influenza infection. However, the task of achieving adequate vaccination rates remains a global challenge. It is unclear whether delayed influenza vaccination is useful for influenza patients. We conducted this study to investigate whether delayed vaccination can reduce mortality in these patients.
methodsThis retrospective cohort study was conducted by reference to the Medical Information Mart for Intensive Care IV (MIMIC-IV) 3.0 database, focusing on patients admitted to the ICU with a diagnosis of influenza. Patients were divided into two groups on the basis of post-admission vaccine use. Propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) were applied to reduce baseline imbalance. The primary outcome was 28-day mortality. Regression analysis and machine learning models, including the Boruta algorithm and LASSO analysis, were used to assess the association between postadmission influenza vaccination use and prognosis results. Sensitivity and subgroup analyses were conducted to evaluate the robustness of the findings.
resultsThis study focused on a cohort of 277 influenza patients from 2008 to 2022. Following the implementation of a 1:1 nearest-neighbor PSM procedure, 164 patients were successfully matched. In the PSM cohort, delayed vaccination was not associated with 28-day mortality (Model I: RR, 1.07; 95 % CI, 0.55-2.08; P=0.838; Model II: RR, 0.84; 95 % CI, 0.44-1.61; P = 0.602; Model III: RR, 0.81; 95 % CI, 0.43-1.56; P = 0.534). In the IPTW cohort, the association remained non-significant (Model I: RR, 1.22; 95 % CI, 0.73-2.03; P=0.446; Model II: RR, 1.12; 95 % CI, 0.66-1.91; P=0.662; Model III: RR, 1.17; 95 % CI, 0.72-1.88; P = 0.524). The secondary outcomes, including 60-day mortality, 90-day mortality, ICU mortality and hospital mortality, use of continuous renal replacement therapy and need for mechanical ventilation, remained consistent.
conclusionsOur study revealed that delayed vaccination did not improve outcomes for critically ill influenza patients, thus highlighting the urgent need for early vaccination to reduce the severity of the disease and protect vulnerable people.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.